Terms: = Germ cell tumor AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Diagnosis
14 results:
1. Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas.
Setyawan NH; Choridah L; Nugroho HA; Malueka RG; Dwianingsih EK
Cancer Imaging; 2024 Jan; 24(1):3. PubMed ID: 38167551
[TBL] [Abstract] [Full Text] [Related]
2. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors.
He Y; Zhao F; Han Q; Zhou Y; Zhao S
BMC Cancer; 2021 Feb; 21(1):141. PubMed ID: 33557782
[TBL] [Abstract] [Full Text] [Related]
4. Early diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
5. Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors.
Terra Md SBSP; Xie Md PhD H; Boland Md JM; Mansfield Md AS; Molina Md PhD JR; Roden Md AC
Hum Pathol; 2019 Dec; 94():78-85. PubMed ID: 31499081
[TBL] [Abstract] [Full Text] [Related]
6. False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
Nijhuis AAG; Dieng M; Khanna N; Lord SJ; Dalton J; Menzies AM; Turner RM; Allen J; Saw RPM; Nieweg OE; Thompson JF; Morton RL
Ann Surg Oncol; 2019 Jun; 26(6):1860-1868. PubMed ID: 30911946
[TBL] [Abstract] [Full Text] [Related]
7. The importance of expressing PDCD4 and PDCD5 anti-oncogenes in glioma.
Wang C; Li JK; Li HZ; Gong HD
J Biol Regul Homeost Agents; 2018; 32(3):731-736. PubMed ID: 29921407
[TBL] [Abstract] [Full Text] [Related]
8. Central neurocytoma: Clinical characteristics, patterns of care, and survival.
Dutta SW; Kaleem TA; Muller DA; Peterson J; Harrell AC; Quinones-Hinojosa A; Trifiletti DM
J Clin Neurosci; 2018 Jul; 53():106-111. PubMed ID: 29685410
[TBL] [Abstract] [Full Text] [Related]
9. Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study.
Hempel JM; Schittenhelm J; Brendle C; Bender B; Bier G; Skardelly M; Tabatabai G; Castaneda Vega S; Ernemann U; Klose U
Eur J Radiol; 2017 Oct; 95():202-211. PubMed ID: 28987669
[TBL] [Abstract] [Full Text] [Related]
10. Serum MicroRNA-125b as a Potential Biomarker for Glioma diagnosis.
Wei X; Chen D; Lv T; Li G; Qu S
Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
[TBL] [Abstract] [Full Text] [Related]
11. Persistent ovarian masses and pregnancy outcomes.
Goh WA; Rincon M; Bohrer J; Tolosa JE; Sohaey R; Riaño R; Davis J; Zalud I
J Matern Fetal Neonatal Med; 2013 Jul; 26(11):1090-3. PubMed ID: 23356452
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of apparent diffusion coefficient with Ki-67 in the diagnosis of gliomas.
Yin Y; Tong D; Liu XY; Yuan TT; Yan YZ; Ma Y; Zhao R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):503-8. PubMed ID: 23134828
[TBL] [Abstract] [Full Text] [Related]
13. Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer.
Romei C; Ugolini C; Cosci B; Torregrossa L; Vivaldi A; Ciampi R; Tacito A; Basolo F; Materazzi G; Miccoli P; Vitti P; Pinchera A; Elisei R
Thyroid; 2012 May; 22(5):476-81. PubMed ID: 22404432
[TBL] [Abstract] [Full Text] [Related]
14. Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma.
Braun MM; Tucker MA; Devesa SS; Hoover RN
Melanoma Res; 1994 Aug; 4(4):235-41. PubMed ID: 7950359
[TBL] [Abstract] [Full Text] [Related]